bioAffinity Technologies, Inc. Increase (Decrease) in Deferred Revenue
bioAffinity Technologies, Inc. (BIAF) reported Increase (Decrease) in Deferred Revenue of -$11.27 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-07
- bioAffinity Technologies, Inc. increase (decrease) in deferred revenue for the quarter ending 2026-06-30 was $0.00.
- bioAffinity Technologies, Inc. increase (decrease) in deferred revenue for the quarter ending 2026-03-31 was -$11.27K.
- bioAffinity Technologies, Inc. increase (decrease) in deferred revenue for the quarter ending 2025-12-31 was $4.49K.
- bioAffinity Technologies, Inc. increase (decrease) in deferred revenue for the quarter ending 2024-12-31 was $0.00.
- bioAffinity Technologies, Inc. increase (decrease) in deferred revenue for fiscal 2025 was $18.00K.
- bioAffinity Technologies, Inc. increase (decrease) in deferred revenue for fiscal 2024 was -$8.65K, a 126.18% decline from fiscal 2023.
- bioAffinity Technologies, Inc. increase (decrease) in deferred revenue for fiscal 2023 was $33.06K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$11.27K 10-Q · filed 2026-08-07 | -$6.78K derived: sum of 3 quarters · filed 2026-08-07 | |
| 2026-03-31 | -$11.27K 10-Q · filed 2026-05-11 | -$6.78K derived: sum of 2 quarters · filed 2026-05-11 | ||
| 2025-12-31 | $4.49K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $18.00K 10-K · filed 2026-03-16 | ||
| 2025-09-30 | $13.51K 10-Q · filed 2025-11-14 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$1.73K derived: sum of 2 quarters · filed 2026-03-16 | -$5.77K derived: sum of 3 quarters · filed 2026-03-16 | -$8.65K 10-K · filed 2026-03-16 |
| 2024-09-30 | -$1.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$5.77K derived: sum of 2 quarters · filed 2025-11-14 | -$8.65K 10-Q · filed 2025-11-14 | -$13.85K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$4.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$6.92K 10-Q · filed 2025-08-14 | -$12.12K derived: sum of 3 quarters · filed 2025-08-14 | -$16.61K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$2.88K 10-Q · filed 2025-05-15 | -$8.08K derived: sum of 2 quarters · filed 2025-05-15 | -$12.58K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | -$5.19K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$9.69K derived: sum of 2 quarters · filed 2025-03-31 | $33.06K 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$4.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $38.25K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $42.75K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |